Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Andreas Samson who wrote (5906)	3/16/1998 1:23:00 PM
From: Whipsaw	Read Replies (1) \| Respond to of 23519

Thanks for posting the link to that one-sided Viagra article. It seems that Muse was not even mentioned. While a family paper can discuss taking pills and injections (concepts with which even children are familiar), I think newspapers are much less comfortable discussing Muse's method of administration. It's just a bit too "clinical" for the general readership. Muse has never had much help from the popular press.

To: Andreas Samson who wrote (5906)	3/16/1998 3:02:00 PM
From: RT	Read Replies (2) \| Respond to of 23519

Andreas Samson, Fox 5 Atlanta News did a 5 minute segments on this exact article several weeks ago.The viewer response was so overwhelming that they did two additional follow up pieces. Don't be surprised if the LA TV News networks don't due likewise. Vivus's pathetic PR department is no match for the talent at Pfizer. IMO, the sooner Leland packs his underwear and leaves, the better off will all be. Vivus needs a seasoned leader who knows how to execute. Vivus supposedly builds a plant in record time and now we wait for what appears to be a lifetime to get the dam thing inspected and certified. By the time Leland gets this plant certified we may not need it. What really frosts my butt is the continued reduced output for another quarter. Leland's poor leadership has cost this company dearly. He has become a liability and it's time to find a qualified replacement who can lead this company forward. RT